David Boettiger

David Boettiger is a Conjoint Associate Professor at the University of Newcastle's School of Medicine and Public Health, where he applies expertise in epidemiology and health economics to address global infectious disease challenges. His research on HIV and viral hepatitis has directly influenced clinical guidelines in Australia and internationally, improving health outcomes for affected populations. As the research lead for FluTracking, Australia's only community-level respiratory infection surveillance system, he plays a critical role in the National Influenza Surveillance Program.

Dr. Boettiger holds a Doctor of Philosophy from the University of New South Wales, alongside a Bachelor of Biomedical Science and Master of Pharmacy from the University of Newcastle. His educational background in both clinical and research disciplines informs his interdisciplinary approach to public health challenges.

His primary research interests span infectious disease epidemiology, health economics, and public health policy, with particular focus on HIV, viral hepatitis, respiratory viruses, and antimicrobial resistance. Through advanced analysis of large datasets and quantitative modeling, his work addresses critical questions in disease prevention, detection, and management across diverse global contexts including Australia, Thailand, Mali, and Indonesia.

Analysis of Dr. Boettiger's recent publications reveals a strong emphasis on practical public health applications, with research spanning HIV treatment optimization, pandemic response strategies, antimicrobial stewardship, and innovative disease surveillance approaches. His work consistently bridges epidemiological research with health economic evaluation, providing evidence for policymakers on cost-effective interventions.

Dr. Boettiger has secured significant research funding as Chief Investigator on NHMRC and UK-MRC grants totaling over $7.1 million, demonstrating the impact and relevance of his work to national and international health priorities. His FluTracking initiative represents a major contribution to Australia's public health infrastructure for monitoring respiratory infections at the community level.

As research lead for FluTracking, Dr. Boettiger oversees a team that integrates data from multiple surveillance systems, cohort studies, and clinical trials to evaluate the population impact of respiratory viruses and assess the effectiveness of public health measures. His collaborative approach brings together clinical, laboratory, and public health experts to advance the goal of creating a world where respiratory infections are rare, rapidly diagnosed, and easily treated.